Lung Cancer Research Review, Issue 36

In this issue:

Pembrolizumab vs chemotherapy in PD-L1-expressing NSCLC
Blood TMB: a biomarker for immunotherapy in NSCLC?
Pemetrexed + cisplatin + nintedanib in unresectable MPM
Diagnostic accuracy of WB-MRI vs standard pathways
Atezolizumab + chemotherapy as first-line therapy in nonsquamous NSCLC
Prophylactic irradiation of tracts in MPM
Local consolidative therapy for oligometastatic NSCLC
Association of cardiorespiratory fitness and lung/colorectal cancer
Efficacy of ICIs in KRAS-mutant NSCLC

Please login below to download this issue (PDF)